PDF herunterladen
CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2019; 77(05): 357-365
DOI: 10.1590/0004-282X20190054
View and Review

Neurocysticercosis and HIV Infection: what can we learn from the published literature?

Neurocisticercosis e infección por VIH: ¿Qué se puede aprender de la literatura reportada?
Omar Herrera Vazquez 
1   Instituto de Investigaciones Biomédicas, Unidad de Neuroinflamación, UNAM, Ciudad de México, México
2   Instituto Nacional de Neurología y Neurocirugía, Clínica de Neurocisticercosis. Ciudad de México, México
,
Matthew L. Romo 
3   School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong. Hong Kong
,
Agnès Fleury 
1   Instituto de Investigaciones Biomédicas, Unidad de Neuroinflamación, UNAM, Ciudad de México, México
2   Instituto Nacional de Neurología y Neurocirugía, Clínica de Neurocisticercosis. Ciudad de México, México
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

ABSTRACT

Infections caused by the human immunodeficiency virus (HIV) and by the larvae of Taenia solium (i.e., cysticercosis) are still widespread in many developing countries. Both pathologies modify host immune status and it is possible that HIV infection may modulate the frequency and pathogeny of cysticercosis of the central nervous system (i.e., neurocysticercosis [NCC]).

Objective: To describe published cases of NCC among HIV-positive patients and to evaluate whether the characteristics of NCC, including frequency, symptoms, radiological appearance, and response to treatment differed between HIV-positive and HIV-negative patients.

Methods: Forty cases of NCC/HIV co-infected patients were identified in the literature. Clinical and radiological characteristics, as well as response to treatment, were compared with non-matching historical series of NCC patients without HIV infection.

Results: Most of these patients had seizures and multiple vesicular parasites located in parenchyma. Clinical and radiological characteristics were similar between HIV-positive and HIV-negative patients with NCC, as well as between immunocompromised and non-immunocompromised HIV-positive patients.

Conclusion: Our review did not reveal clear interactions between HIV and NCC. This may be partially due to the small number of cases and reliance on published research. A systematic, multi-institutional effort aiming to report all the cases of this dual pathology is needed to confirm this finding and to clarify the possible relationship between both pathogens.

RESUMO

Las infecciones causadas por el virus de inmunodeficiencia humana (VIH) y la larva de la Tenia solium siguen estando diseminadas en países en vías de desarrollo. Ambas patologías modifican el estado inmune y es posible que la infección por el VIH module la frecuencia y la patología de la neurocisticercosis (NCC).

Objetivo: Describir los casos publicados de NCC en los pacientes VIH positivos y evaluar si las características de la NCC, incluyendo frecuencia, síntomas, presentación radiológica, respuesta a tratamiento, difieren entre los sujetos VIH positivos y VIH negativos.

Métodos: Cuarenta casos con coinfección NCC/VIH fueron identificados en la literatura. Se compararon sus características clínico-radiológicas, así como su respuesta al tratamiento con diferentes series de casos históricos no pareados.

Resultados: La mayoría de los pacientes NCC/VIH tenían epilepsia y múltiples parásitos vesiculares en el parénquima. Las características clínico-radiológicas de la NCC así como la evolución de los pacientes fueron similares entre pacientes VIH positivos y negativos, así como entre pacientes VIH inmunocomprometidos y no inmunocomprometidos.

Conclusión: No encontramos interacciones claras entre VIH y NCC. Este resultado puede haber sido influenciado por el pequeño número de casos y la parcialidad de la información publicada. Un esfuerzo multiinstitucional, sistemático encaminado a reportar todos los casos de esta patología dual es necesario para confirmar estos resultados y esclarecer la relación entre patógenos.

Keywords:

HIV - coinfection - Taenia solium - neurocysticercosis

Palabras-clave:

HIV - coinfección - Taenia solium - neurocisticercosis


Publikationsverlauf

Eingereicht: 21. Dezember 2018

Angenommen: 11. Februar 2019

Artikel online veröffentlicht:
16. August 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Fact sheet-Latest statistics on the status of the AIDS epidemic. Geneva. UNAIDS; [cited 2017 Oct 30]. Available from: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
  • 2 Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009 Apr;58 RR-4:1-207.
  • 3 Carpio A, Fleury A, Romo ML, Abraham R. Neurocysticercosis: the good, the bad, and the missing. Expert Rev Neurother. 2018 Apr;18(4):289-301. https://doi.org/10.1080/14737175.2018.1451328
  • 4 Torgerson PR, Devleesschauwer B, Praet N, Speybroeck N, Willingham AL, Kasuga F, et al. World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: A data synthesis. PLoS Med. 2015 Dec;12(12):e1001920. https://doi.org/10.1371/journal.pmed.1001920
  • 5 Fleury A, Cardenas G, Adalid-Peralta L, Fragoso G, Sciutto E. Immunopathology in Taenia solium neurocysticercosis. Parasite Immunol. 2016 Mar;38(3):147-57. https://doi.org/10.1111/pim.12299
  • 6 Martins-Melo FR, Ramos AN Jr, Cavalcanti MG, Alencar CH, Heukelbach J. Neurocysticercosis-related mortality in Brazil, 2000-2011: epidemiology of a neglected neurologic cause of death. Acta Trop. 2016 Jan;153:128-36. https://doi.org/10.1016/j.actatropica.2015.10.011
  • 7 Marcin Sierra M, Arroyo M, Cadena Torres M, Ramírez Cruz N, García Hernández F, Taboada D, et al. Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory features. PLoS Negl Trop Dis. 2017 Jun;11(6):e0005646. https://doi.org/10.1371/journal.pntd.0005646
  • 8 Magadi M, Desta M. A multilevel analysis of the determinants and cross-national variations of HIV seropositivity in sub-Saharan Africa: evidence from the DHS. Health Place. 2011 Sep;17(5):1067-83. https://doi.org/10.1016/j.healthplace.2011.06.004
  • 9 Flammer Anikpeh Y, Grimm F, Lindenblatt N, Zinkernagel A. It isn't always caviar. BMJ Case Rep. 2014 Apr;2014 apr01 1:bcr2013200078. https://doi.org/10.1136/bcr-2013-200078
  • 10 Carpio A, Fleury A, Romo ML, Abraham R, Fandiño J, Durán JC, et al. New diagnostic criteria for neurocysticercosis: reliability and validity. Ann Neurol. 2016 Sep;80(3):434-42. https://doi.org/10.1002/ana.24732
  • 11 Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory testing for the diagnosis of HIV infection: updated recommendations. Atlanta, Georgia, USA; 2014 [cited 2017 Oct 30]. Available from: https://stacks.cdc.gov/view/cdc/23447
  • 12 Schmidt V, Kositz C, Herbinger KH, Carabin H, Ngowi B, Naman E, et al. Association between Taenia solium infection and HIV/AIDS in northern Tanzania: a matched cross sectional-study. Infect Dis Poverty. 2016 Dec;5(1):111. https://doi.org/10.1186/s40249-016-0209-7
  • 13 Fleury A, Moreno García J, Valdez Aguerrebere P, de Sayve Durán M, Becerril Rodríguez P, Larralde C, et al. Neurocysticercosis, a persisting health problem in Mexico. PLoS Negl Trop Dis. 2010 Aug;4(8):e805. https://doi.org/10.1371/journal.pntd.0000805
  • 14 Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis. 2011 May;5(5):e1152. https://doi.org/10.1371/journal.pntd.0001152
  • 15 Serpa JA, Graviss EA, Kass JS, White AC Jr. Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore). 2011 Jan;90(1):81-6. https://doi.org/10.1097/MD.0b013e318206d13e
  • 16 Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms: a study of 753 cases. Arch Intern Med. 1985 Mar;145(3):442-5. https://doi.org/10.1001/archinte.1985.00360030074016
  • 17 Sotelo J, del Brutto OH, Penagos P, Escobedo F, Torres B, Rodriguez-Carbajal J, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol. 1990 Apr;237(2):69-72. https://doi.org/10.1007/BF00314663
  • 18 Figueroa JJ, Davis LE, Magalhaes A. Extraparenchymal neurocysticercosis in Albuquerque, New Mexico. J Neuroimaging. 2011 Jan;21(1):38-43. https://doi.org/10.1111/j.1552-6569.2009.00452.x
  • 19 Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med. 2006 Jul;145(1):43-51. https://doi.org/10.7326/0003-4819-145-1-200607040-00009
  • 20 Monteiro L, Almeida-Pinto J, Stocker A, Sampaio-Silva M. Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients. J Neurol. 1993 Nov;241(1):15-21. https://doi.org/10.1007/BF00870666
  • 21 Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004 Jan;350(3):249-58. https://doi.org/10.1056/NEJMoa031294
  • 22 Thornton CA, Houston S, Latif AS. Neurocysticercosis and human immunodeficiency virus infection: a possible association. Arch Neurol. 1992 Sep;49(9):963-5. https://doi.org/10.1001/archneur.1992.00530330087021
  • 23 White AC Jr, Dakik H, Diaz P. Asymptomatic neurocysticercosis in a patient with AIDS and cryptococcal meningitis. Am J Med. 1995 Jul;99(1):101-2. https://doi.org/10.1016/S0002-9343(99)80113-2
  • 24 Soto Hernandez JL, Ostrosky Zeichner L, Tavera G, Gomez Avina A. Neurocysticercosis and HIV infection: report of two cases and review. Surg Neurol. 1996 Jan;45(1):57-61. https://doi.org/10.1016/0090-3019(95)00259-6
  • 25 Delobel P, Signate A, El Guedj M, Couppie P, Gueye M, Smadja D, et al. Unusual form of neurocysticercosis associated with HIV infection. Eur J Neurol. 2004 Jan;11(1):55-8. https://doi.org/10.1046/j.1351-5101.2003.00696.x
  • 26 Modi M, Mochan A, Modi G. Management of HIV-associated focal brain lesions in developing countries. QJM. 2004 Jul;97(7):413-21. https://doi.org/10.1093/qjmed/hch080
  • 27 Kumwenda JJ, Mateyu G, Kampondeni S, Dam AP, van Lieshout L, Zijlstra EE. Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Stroke. 2005 May;36(5):960-4. https://doi.org/10.1161/01.STR.0000162585.97216.ef
  • 28 Pandey K, Sinha PK, Das VR, Sur D, Kumar N, Bhattacharya SK. Neurocysticercosis in a patient with visceral leishmaniasis co-infected with HIV: a case report. Infect Dis Clin Pract. 2005;13(3):144-5. https://doi.org/10.1097/01.idc.0000166957.37141.ff.
  • 29 Chianura L, Sberna M, Moioli C, Villa MR, Orcese C, Causarano R. Neurocysticercosis and human immunodeficiency virus infection: a case report. J Travel Med. 2006 Nov-Dec ;13(6)376-80. https://doi.org/10.1111/j.1708-8305.2006.00074.x
  • 30 Lillie P, Parsonage M, Barlow G, Thaker H. Neurocysticercosis with communicating hydrocephalus in an HIV-positive subject. HIV Med. 2006;7 Suppl. 1:37.
  • 31 Prasad S, MacGregor RR, Tebas P, Rodriguez LB, Bustos JA, White AC Jr. Management of potential neurocysticercosis in patients with HIV infection. Clin Infect Dis. 2006 Feb;42(4):e30-4. https://doi.org/10.1086/499359
  • 32 Ramos JM, Masia M, Padilla S, Bernal E, Martin-Hidalgo A, Gutiérrez F. Fatal infection due to larval cysts of cestodes (neurocysticercosis and hydatid disease) in human immunodeficiency virus (HIV) infected patients in Spain: report of two cases. Scand J Infect Dis. 2007;39(8):719-23. https://doi.org/10.1080/00365540701242392
  • 33 Serpa JA, Moran A, Goodman JC, Giordano TP, White AC Jr. Neurocysticercosis in the HIV era: a case report and review of the literature. Am J Trop Med Hyg. 2007 Jul;77(1):113-7. https://doi.org/10.4269/ajtmh.2007.77.113
  • 34 Jung A, Thaker H, Ming A. Casualties of conflict: a case report of neurocysticercosis, reactivation of toxoplasmosis in an HIV positive pregnant patient. Eur J Neurol. 2008;15 Suppl. 3:342.
  • 35 Okome-Nkoumou MM, Ondounda M, Dzeing-Ella A, Mounguengui D, Madjinou MI, Clevenbergh P, et al. Epileptiform seizures revealing neurocysticercosis: report of two clinical cases in Libreville, Gabon. Trop Doct. 2010 Oct;40(4):235-7. https://doi.org/10.1258/td.2010.090493
  • 36 Gupta V, Yadav TP. “Starry sky”-appearing neurocysticercosis in paediatric HIV infection. J Indian Acad Clin Med. 2012 Oct;13(4):316-8.
  • 37 Motsepe T, Ackerman D. Spinal and vertebral neurocysticercosis in an HIV-positive female patient. SAJEI. 2012;27(3):133-6. https://doi.org/10.1080/10158782.2012.11441499.
  • 38 Giordani MT, Tamarozzi F, Cattaneo F, Brunetti E. Three cases of imported neurocysticercosis in Northern Italy. J Travel Med. 2014 Jan-Feb;21(1):17-23. https://doi.org/10.1111/jtm.12066
  • 39 Millogo A. Epilepsy revealing neurocysticercosis in an HIV positive patient with subcutaneous nodules. North Afr Middle East Epilepsy J. 2013 Jan-Feb;2(1):8-9.
  • 40 Taha H, Das S. Cerebral mass in HIV infection. BMJ. 2013 Oct;347 oct24 2:f6314. https://doi.org/10.1136/bmj.f6314
  • 41 Anand KS, Wadhwa A, Garg J, Mahajan RK. HIV-Associated Neurocysticercosis. J Int Assoc Provid AIDS Care. 2015 Mar-Apr;14(2):120-2. https://doi.org/10.1177/2325957414555232
  • 42 Anayo N, Agba L, Poko M, et al. Neurocysticercosis and HIV in 4 cases observed at chu de lome. J Rech Sci Univ Lom (Togo). 2015;17:331-6.
  • 43 Martins JC, Cruzeiro MM, Pires LA. Neurotoxoplasmose e neurocisticercose em paciente com AIDS: relato de caso. Rev Neurocienc. 2015;23(3):443-50. https://doi.org/10.4181/RNC.2015.23.03.1043.08p
  • 44 Sáenz B, Ruíz-Garcia M, Jiménez E, Hernández-Aguilar J, Suastegui R, Larralde C, et al. Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults. Pediatr Infect Dis J. 2006 Sep;25(9):801-3. https://doi.org/10.1097/01.inf.0000233548.81204.97
  • 45 Jessurun J, Barrón-Rodríguez LP, Fernández-Tinoco G, Hernández-Avila M. The prevalence of invasive amebiasis is not increase in patients with AIDS: short communication. AIDS. 1992 Mar;6(3):307-10. https://doi.org/10.1097/00002030-199203000-00008
  • 46 Purvey S, Lu K, Mukkamalla SK, Anandi P, Dumitriu B, Kranick S, et al. Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review. Transpl Infect Dis. 2015 Jun;17(3):456-62. https://doi.org/10.1111/tid.12392
  • 47 Gordillo-Paniagua G, Muñoz-Arizpe R, Ponsa-Molina R. Unusual complication in a patient with renal transplantation: cerebral cysticercosis. Nephron. 1987;45(1):65-7. https://doi.org/10.1159/000184074
  • 48 Barra Valencia V, Moreno Elola-Olaso A, Fundora Suárez Y, Meneu Díaz JC, Jiménez de los Galanes SF, Pérez Saborido B, et al. Second case of neurocysticercosis in a patient with liver transplantation (first case in Spain): a case report. Transplant Proc. 2007 Sep;39(7):2454-7. https://doi.org/10.1016/j.transproceed.2007.07.049
  • 49 Hoare M, Gelson WT, Antoun N, Alexander GJ. Early recurrence of neurocysticercosis after orthotopic liver transplant. Liver Transpl. 2006 Mar;12(3):490-1. https://doi.org/10.1002/lt.20643
  • 50 Mauad T, Battlehner CN, Bedrikow CL, Capelozzi VL, Saldiva PH. Case report: massive cardiopulmonary cysticercosis in a leukemic patient. Pathol Res Pract. 1997;193(7):527-9. https://doi.org/10.1016/S0344-0338(97)80108-2
  • 51 Sanz CR. Host response in childhood neurocysticercosis. Some pathological aspects. Childs Nerv Syst. 1987;3(4):206-7. https://doi.org/10.1007/BF00274046
  • 52 Fleury A, Escobar A, Fragoso G, Sciutto E, Larralde C. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg. 2010 Apr;104(4):243-50. https://doi.org/10.1016/j.trstmh.2010.01.005
  • 53 Manzardo C, Guardo AC, Letang E, Plana M, Gatell JM, Miro JM. Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review. Expert Rev Anti Infect Ther. 2015 Jun;13(6):751-67. https://doi.org/10.1586/14787210.2015.1029917
  • 54 Cárdenas G, Fragoso G, Rosetti M, Uribe-Figueroa L, Rangel-Escareño C, Saenz B, et al. Neurocysticercosis: the effectiveness of the cysticidal treatment could be influenced by the host immunity. Med Microbiol Immunol. 2014 Dec;203(6):373-81. https://doi.org/10.1007/s00430-014-0345-2
  • 55 Dunay GA, Tóth I, Eberhard JM, Degen O, Tolosa E, van Lunzen J, et al. Parallel assessment of Th17 cell frequencies by surface marker co-expression versus ex vivo IL-17 production in HIV-1 infection. Cytometry B Clin Cytom. 2016 Nov;90(6):486-92. https://doi.org/10.1002/cyto.b.21352